Anthony Fauci, the 85-year-old retired health official known for leading the U.S. pandemic response, is facing a potential contempt-of-Congress vote. This decision is being considered by the Republican-led Senate Homeland Security and Governmental Affairs Committee after Fauci invoked his Fifth Amendment right during a recent hearing.
Senate Hearing and Fifth Amendment Invocation
During a hearing with the Senate committee, Fauci chose not to answer certain questions, citing his right to avoid self-incrimination. He addressed the committee with an opening statement, expressing respect for the legislative branch despite his decision. Fauci mentioned that past exchanges with the committee covered many of the topics being revisited.
Contentions with Senator Rand Paul
Fauci’s longstanding disagreements with Sen. Rand Paul relate to the pandemic’s origins. Ahead of the recent hearing, Paul distributed over 1,000 pages from Fauci’s private diaries, suspecting them to reveal hidden uncertainties about what initiated the pandemic.
Discussion on Testimony Immunity
At the hearing, Paul mentioned that underlying immunity from prosecution should ease Fauci’s concerns about testifying. This immunity traces back to a pardon by President Joe Biden, protecting Fauci’s actions from 2014 to January 2025. However, this protection doesn’t cover actions beyond that period or include current testimony.
Potential Legal Consequences
If a contempt vote passes, the Justice Department will decide on prosecuting Fauci. While rare, similar contempt cases led to imprisonment for two former Trump advisers during Biden’s tenure. Democrats are concerned about parallels with prosecutions of other officials Trump has criticized, such as James Comey.

Blakeman Proposes Silent Protest Against NYC Mayor at 9/11 Memorial
Washington IndyCar Race Set to Ignite High Speeds Amid Historical Celebrations
North Carolina Congressman Withdraws Amid Ethics Committee’s Censure Recommendation
Progressive Candidates Face Crucial November Tests
Nominee Todd Blanche Under Scrutiny Amid Epstein-Related Lawsuit
GOP Dispute Over Hemp Products Delays Government Funding Bill